We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults (CTCOVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04313127
Recruitment Status : Completed
First Posted : March 18, 2020
Last Update Posted : August 4, 2021
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
Jiangsu Province Centers for Disease Control and Prevention
Hubei Provincial Center for Disease Control and Prevention
Tongji Hospital
Information provided by (Responsible Party):
CanSino Biologics Inc.